ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LMNX Luminex Corporation

36.99
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Luminex Corporation NASDAQ:LMNX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 36.99 36.94 36.98 0 01:00:00

Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020

22/10/2020 12:00pm

PR Newswire (US)


Luminex (NASDAQ:LMNX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Luminex Charts.

AUSTIN, Texas, Oct. 22, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020. A press release announcing the results is scheduled for release after the close of trading on that date.

Management will hold a conference call to discuss the operating highlights and financial results for the third quarter ended September 30, 2020 on November 5, 2020, at 5:00 p.m. Eastern Time.

The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Luminex section and access the Investor Relations link. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.

About Luminex Corporation

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.

Luminex Corporate Contact: 
Harriss Currie
Sr. Vice President, Finance and CFO
512.219.8020
hcurrie@luminexcorp.com

Investor Relations Contact:
Carla Stanaford
937.469.2120
cstanaford@luminexcorp.com

Luminex logo. (PRNewsFoto/Luminex Corporation)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-third-quarter-earnings-release-scheduled-for-november-5-2020-301157528.html

SOURCE Luminex Corporation

Copyright 2020 PR Newswire

1 Year Luminex Chart

1 Year Luminex Chart

1 Month Luminex Chart

1 Month Luminex Chart

Your Recent History

Delayed Upgrade Clock